基本药物制度背景下慢性病患者用药依从性影响因素分析

发布时间：2018-05-08 15:14

本文选题：基本药物制度 + 慢性病患者　；参考：《中国公共卫生》2017年07期

【摘要】：目的了解基本药物制度背景下慢性病患者用药依从性的影响因素。方法利用Morisky患者用药依从性问卷测量1 200名慢性病患者用药依从性,并对数据进行单因素与多因素分析。结果慢性病患者对基本药物制度知晓率为50.7%(608/1 200);63.8%(765/1 200)的慢性病患者用药依从性表现较好,城市患者用药依从性为64.3%(222/345),好于农村的63.5%(543/855),不发达地区患者用药依从性为66.1%(517/782),好于经济发达地区的59.3%(248/418),40岁人群患者用药依从性为71.6%(96/134),好于其他年龄组的62.8%(669/1 066);慢性病患者用药依从性的影响因素主要包括患者用药偏好、基层医疗机构的药物供应与用药指导等。结论当前应在基本药物制度顶层设计优化、慢性病患者用药偏好矫正与基层医疗机构用药指导方面加大建设力度。
[Abstract]:Objective to investigate the influencing factors of drug compliance in patients with chronic diseases under the background of essential drug system. Methods Morisky compliance questionnaire was used to measure the drug compliance of 1 200 patients with chronic diseases, and the data were analyzed by univariate and multivariate analysis. Results the patients with chronic diseases whose awareness rate of essential drug system was 50.780 / 1 200 / 63.8% showed better drug compliance. The drug compliance of urban patients was 64.32 / 345m, better than that of 63.535 / 855 in rural areas, 66.1% of 517 / 782% in underdeveloped areas, better than that of 59.38% 41840 years old in economically developed areas, 71.69696 / 134%, and better than 62.866 / 1066 chronic diseases in other age groups. The influencing factors of compliance include patients' drug preference, Drug supply and medication guidance in primary medical institutions. Conclusion at present, we should optimize the design of essential drug system, rectify the drug preference of patients with chronic diseases, and strengthen the construction of drug use guidance in primary medical institutions.
【作者单位】：潍坊医学院公共卫生与管理学院;
【基金】：国家自然科学基金(71373182) 教育部人文社会科学研究规划基金青年基金(15YJCZH065)
【分类号】：R95

【相似文献】